Wells Fargo Raises Kyverna Therapeutics (KYTX) PT to $27 on Confidence in KYV-101 Stiff Person Syndrome Trial Readout
Kyverna Therapeutics Inc. (NASDAQ:KYTX) is one of the best young stocks with huge upside potential.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GordonMD Global Investments Craig Gordon | 4,391,818 | $41,283,089 | 29.6% | |
| 2. | Deerfield Management James E. Flynn | 2,000,000 | $18,800,000 | 0.24% | |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 1,666,666 | $15,666,660 | 0.02% | |
| 4. | AIGH Investment Partners Orin Hirschman | 1,500,000 | $14,100,000 | 3.41% | |
| 5. | Balyasny Asset Management Dmitry Balyasny | 980,869 | $9,220,169 | 0.01% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.50 | 133,333 | $999,997.50 | 869,317 | 2025-12-18 | Filing | |
| $7.50 | 133,333 | $999,997.50 | 869,317 | 2025-12-18 | Filing | |
| $22.00 | 583 | $12,826.00 | 583 | 2024-02-12 | Filing | |
| $22.00 | 252,553 | $5,556,166.00 | 252,553 | 2024-02-12 | Filing | |
| $22.00 | 450,000 | $9,900,000.00 | 3,163,868 | 2024-02-12 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.20 | 23,998 | $292,775.60 | 22,636 | 2025-12-15 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,126,119 | $38,785,519 | 2% | |
| 2. | 3,110,000 | $29,234,000 | 2.24% | |
| 3. | 1,781,257 | $16,743,815 | 0% | |
| 4. | 1,002,495 | $9,423,453 | 0% | |
| 5. | 989,054 | $9,297,108 | 0.7% |